NCT06977711
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06977711
Title Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors The University of Texas Health Science Center at San Antonio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University Hospital System RECRUITING San Antonio Texas 78228 United States Details
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field